What is the latest Veracyte (VCYT) news?

MoveSurge Every market-moving story. Fast. Clear. Complete.

Go real time Sign In

Never miss the news that moves markets. Protecting traders and investors since 2006. Every market-moving story. Fast. Clear. Complete. Wide coverage Global markets and U.S. stocks of every size. Fast Important news reaches you as it breaks. Clear Plain words and extra context only when you need it.

Analyst-led coverage since 2006 Covers: Global markets, all sizes of U.S. stocks, central banks, economic data, politics, oil, gold, and more. Direct sources included

Veracyte (VCYT) News Today

No Veracyte (VCYT) headline in the last 7 days came with a measured price move.

Ask ChatGPT about VCYT Ask Claude about VCYT Connect MoveSurge to your assistant

Why Veracyte (VCYT) moved: the full explanation

Every VCYT headline we timestamp, with the price move measured one minute after we published it and at the end of the measured window.

What moved VCYT — last 7 days

No VCYT headline has appeared in our news feed with a measured price move in the last 7 days. This page fills automatically the next time one does.

Our analysis

Why Was Veracyte Stock Moving on Sep 14, 2026?

Monday, Sep 14, 2026 · Veracyte acquired Convergent Genomics and its UroAmp urine test for $150 million in cash plus up to $30 million in milestones, with a first test planned …

Related coverage

The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources

Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.